Piper Sandler Upgrades Neogen to Overweight, Raises Price Target to $14

Neogen Corp

Neogen Corp

NEOG

0.00

Piper Sandler analyst David Westenberg upgrades Neogen (NASDAQ: NEOG) from Neutral to Overweight and raises the price target from $13 to $14.